PharmiWeb.com - Global Pharma News & Resources
26-Mar-2020

Global Alopecia Treatment (Hair Loss) Market To witness remarkable growth By 2026|Cipla, Viviscal, Dr. Reddy’s Laboratories Ltd., Regaine,Kirkland Signature, Vitabiotics & Others

Global Alopecia Treatment (Hair Loss) Market is expected to rise from its initial estimated value of USD 8.21 billion in 2018 to an estimated value of USD 12.40 billion by 2026 registering a CAGR of 5.3% in the forecast period of 2019-2026. This rise in the market can be attributed to the rising geriatric population along with high demand for surgical hair transplant and changing lifestyle.

This Alopecia Treatment (Hair Loss) market analysis report profiles leading companies of the market along with the emerging new ventures who are creating an impact on the global market with their latest innovations and technologies. The study includes information on key segmentation of the global Alopecia Treatment (Hair Loss)  market on the basis of type/product, application and geography (country/region). Each of the segments included in the report is studied in relation to different factors such as market size, market share, value, growth rate and other quantitative information. The competitive analysis included in this Alopecia Treatment (Hair Loss) market study allows readers to understand the difference between players and how they are operating among themselves on global scale. 

Download Sample PDF Copy of Report https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-alopecia-treatment-hair-loss-market

Few of the major market competitors currently working in the alopecia treatment (hair loss) market are

Cipla,

Viviscal,

Dr. Reddy’s Laboratories Ltd.,

Regaine,

Merck & Co., Inc,

Ranbaxy Laboratories Ltd,

Phyto – Alès Groupe,

Kirkland Signature,

Vitabiotics,

Nanogen,

Key Developments in the Market:

In January, 2018, Concert Pharmaceuticals, Inc. announced U.S. FDA granted Fast Track designation for CTP-543, a novel, oral Janus kinase (JAK) inhibitor for the treatment of moderate-to-severe alopecia areata, disease which attacks the hair follicles, leading to hair loss.In May 2018, Histogen, Inc (U.S.) announced that received approval to Investigational New Drug (IND) application from the US Food and Drug Administration (FDA) to study its lead product in female diffuse hair loss.In March 2017, Perrigo Perrigo Company PLC (U.S.) announced the launch of over-the-counter Women’s Rogaine, which helps to regrow hair on top of the scalp.

Table Of Content:

Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Global Alopecia Treatment (Hair Loss) Market Landscape

Part 04: Global Alopecia Treatment (Hair Loss) Market Sizing

Part 05: Global Alopecia Treatment (Hair Loss) Market Segmentation By Product

Part 06: Five Forces Analysis

Part 07: Customer Landscape
Part 08: Geographic Landscape

Part 09: Decision Framework
Part 10: Drivers And Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

 For More Insights Get Detailed TOC   https://www.databridgemarketresearch.com/toc/?dbmr=global-alopecia-treatment-hair-loss-market

Segmentation: Global Alopecia Treatment (Hair Loss) Market

By Disease TypeAndrogenic AlopeciaAlopecia AreataCiatricial AlopeciaTraction AlopeciaAlopecia TotalisBy Drug TypeMinoxidilFinasterideCyclosporineOthersBy GenderMaleFemaleBy Route of AdministrationOralTopicalInjectableBy Distribution ChannelHospitalRetail PharmaciesOnline PharmaciesBy GeographyNorth AmericaSouth AmericaEuropeAsia-PacificMiddle East and Africa

Market Drivers:

Rising geriatric population along with high demand for surgical hair transplant will boost the marketChanging lifestyle along with increase in stress level among working class population can fuel the growth of the market

Market Restraints:

High cost of alopecia treatment (hair loss) is acting as a major restraint for the marketSide effects/allergic reactions by treatment also acting as a major market restraint.

Inquire Regarding This Report  https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-alopecia-treatment-hair-loss-market

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Corporatesales@databridgemarketresearch.com

 

This content has been distributed via WiredRelease press release distribution service. For press release service enquiry, please reach us at contact@wiredrelease.com.

Editor Details

Last Updated: 26-Mar-2020